Related Experiment Videos
Sequence-specific modification of mouse genomic DNA mediated by gene targeting techniques
1Department of Biopathology and Diagnostic Imaging, Tor Vergata University, Rome, Italy.
Cytogenetic and Genome Research
|July 9, 2004
Summary
Gene repair using homologous recombination (HR) offers a precise alternative to traditional gene augmentation for genetic disorders. This review explores oligonucleotide-based gene targeting for in situ gene correction and mouse genome modification.
Area of Science:
- Genetics
- Molecular Biology
- Genomic Medicine
Background:
- The human genome sequence has advanced disease etiology understanding but therapeutic progress lags.
- Traditional gene therapy (gene augmentation) faces deficiencies, prompting exploration of alternative strategies.
- Homologous recombination (HR) enables precise gene repair by targeting mutations in situ.
Purpose of the Study:
- To review oligonucleotide-based gene targeting technologies.
- To discuss applications of these technologies in modifying the mouse genome.
- To highlight HR-based gene repair as a potential clinical therapy for genetic diseases.
Main Methods:
- Review of existing literature on oligonucleotide-based gene targeting.
- Analysis of homologous recombination efficiency in different organisms.
- Exploration of gene targeting strategies for in situ gene correction.
Main Results:
- Homologous recombination is efficient in lower eukaryotes but less so in higher eukaryotes compared to non-homologous recombination.
- Recent advances suggest HR-based gene correction may be viable for clinical therapy.
- Oligonucleotide-based gene targeting offers site-specific gene repair, an alternative to random viral vector integration.
Conclusions:
- Oligonucleotide-based gene targeting presents a promising approach for precise gene repair.
- HR-based gene correction could overcome limitations of traditional gene augmentation therapies.
- Further development of these technologies holds potential for treating genetic disorders.